# QS Capital

> QS Capital is a VC fund in Xiamen backing Medical, Health Care and Fashion. See 13 investments, check sizes, portfolio. Updated Sep 2026.

- Type: VC Fund
- Location: Xiamen, China
- Total investments: 13
- Last investment: Jun 2022
- Lead investor: 8%
- Fund size: $15M
- Last fund: Feb 2017
- Last updated: Sep 2026
- Website: http://www.qianshanvc.com

QS Capital is a VC fund in Xiamen focused on Medical and Health Care. QS Capital makes early-stage investments in biotechnology, medical equipment, and new consumer areas.

## Round sizes

| Stage | Round size |
| --- | --- |
| Angel | $439k–$452k |
| Series A | $1.5M–$3M |
| Series B | $3M–$30M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 4 | 31% |
| Health Care | 4 | 31% |
| Fashion | 3 | 23% |
| E-Commerce | 3 | 23% |
| Consulting | 2 | 15% |

21 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 5 | 38% |
| Angel | 2 | 15% |
| Series B | 2 | 15% |
| Series C | 2 | 15% |
| Seed | 1 | 8% |

6 stages tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| AMCARELAB | AMCARELAB includes three major disciplines : clinical cytogenetics, Clinical Biochemistry, and Clinical Molecular Genetics. | $29.9M | Series B | Jun 09, 2022 |  |
| ChosenMed | ChosenMed is a healthcare company in oncology precision medicine, focusing on early tumor screening and companion diagnosis. |  | Series C | Oct 08, 2021 |  |
| YIAUTO | YIAUTO is an automobile supermarket for tier 3-5 cities in China. | $70M | Series C | Apr 30, 2021 |  |
| MagAssist | Suzhou Xinqing Medical Technology Co., Ltd. was founded in 2017 by Dr. Xu Bozhen, a special expert of the National Youth Thousand People Program and a special professor of Suzhou University. He is a high-tech enterprise with the main goal of developing the world's leading in vitro short-term ventricular assist device (in vitro artificialheart). . The core members of the company's entrepreneurial team are the world's top artificial heart engineering technology experts. With years of experience in overseas artificial heart research and development and productization, the company has developed a domestically produced artificial heart with independent intellectual property rights. |  | Series A | Jul 04, 2019 |  |
| Kameila | Kameila provides an S2B platform that offers global supply chain service and internet celebrity sales channels for women's products. It provides "high-quality supply chain + content e-commerce full case operation" for brand merchants and talents Solutions, customized to create a closed-loop business position of "integration ofquality and efficiency".It was founded in 2016 and is based in Hangzhou, Zhejiang, China. |  | Venture - Series Unknown | Jan 01, 2019 |  |
| ForDearMe | ForDearMe is a E-commerce Start up Based in Hangzhou. | $1.5M | Series A | Aug 10, 2018 |  |
| Zhangfeichongdian | Zhangfeichongdian is a Transportation & Space company. | $2.9M | Series A | Aug 02, 2018 |  |
| Julu Medical | Medical solution provider focusing on cardiac rehabilitation and pulmonary rehabilitation based in Beijing. |  | Series A | Apr 16, 2018 |  |
| XmeBank | XmeBank is a financial services platform that provides loans to companies in the catering industry. The company is headquartered in Beijing, China. |  | Seed | Dec 05, 2017 |  |
| iSTAR | iSTAR develops, packs, and markets clothing products. Their product categories such as clothing, women's clothing, women 's tops, women's trousers, women's dresses, women's suits, women's lingerie, women's clothing accessories, men's tops, men's trousers, men's suits, men's clothingaccessories, children's clothing, kids tops, kids bottoms, kids accessories, shoes and bags, jewelry accessories, digital home appliances, creative home, pet supplies, auto accessories, sporting goods, gift area, and healthy beauty. | $452.1K | Angel | Nov 03, 2017 |  |

10 of 13 investments shown.

## Co-investors
- [Med-Fine Capital](https://shizune.co/investors/profile/med-fine-capital) — VC Fund, 2 deals together
- [Albatross Venture](https://shizune.co/investors/profile/albatross-venture) — VC Fund, 1 deal together
- [Bison Capital (China)](https://shizune.co/investors/profile/bison-capital-china) — VC Fund, 1 deal together
- [BlueRun Ventures](https://shizune.co/investors/profile/bluerun-ventures) — VC Fund, 1 deal together
- [CICC Qide](https://shizune.co/investors/profile/cicc-qide) — VC Fund, 1 deal together
- [Danen Capital](https://shizune.co/investors/profile/danen-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does QS Capital invest in?

QS Capital invests primarily in Medical, Health Care and Fashion startups, most often at Series A and Angel stage. Most of the 13 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is QS Capital's check size?

QS Capital typically joins rounds of $439k–$452k at Angel, $1.5M–$3M at Series A and $3M–$30M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds QS Capital participates in.

### When did QS Capital last invest?

The most recent investment recorded for QS Capital closed in Jun 2022. Shizune tracks 13 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co